Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Toscano

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Genes|October 31, 2018
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic PatientsTeresa Giugliano, Marco Savarese, Arcomaria Garofalo, et al.
JAMA Neurology|April 10, 2023
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical TrialPriya S Kishnani, Jordi Diaz-Manera, Antonio Toscano, et al.
Neurology|August 4, 2025
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-AnalysisMichele Romoli, Maurizio Paciaroni, Nicola Marrone, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trialJordi Diaz-Manera, Priya S Kishnani, Hani Kushlaf, et al.
Journal of Neurology|March 27, 2015
Redefining phenotypes associated with mitochondrial DNA single deletionMichelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP DatabasePietro Emiliano Doneddu, Dario Cocito, Fiore Manganelli, et al.
Journal of Neurology|May 21, 2020
Impact of environmental factors and physical activity on disability and quality of life in CIDPPietro Emiliano Doneddu, Elisa Bianchi, Dario Cocito, et al.
European Journal of Neurology|March 23, 2022
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseasesKatina Aleksovska, Teia Kobulashvili, Joao Costa, et al.
Neurology|June 2, 2023
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical TrialAmel Karaa, Enrico Bertini, Valerio Carelli, et al.
Brain : a Journal of Neurology|July 24, 2024
Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progressionAlexandra Monceau, Rasya Gokul Nath, Xavier Suárez-Calvet, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Genes|October 31, 2018
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic PatientsTeresa Giugliano, Marco Savarese, Arcomaria Garofalo, et al.
JAMA Neurology|April 10, 2023
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical TrialPriya S Kishnani, Jordi Diaz-Manera, Antonio Toscano, et al.
Neurology|August 4, 2025
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-AnalysisMichele Romoli, Maurizio Paciaroni, Nicola Marrone, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trialJordi Diaz-Manera, Priya S Kishnani, Hani Kushlaf, et al.
Journal of Neurology|March 27, 2015
Redefining phenotypes associated with mitochondrial DNA single deletionMichelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP DatabasePietro Emiliano Doneddu, Dario Cocito, Fiore Manganelli, et al.
Journal of Neurology|May 21, 2020
Impact of environmental factors and physical activity on disability and quality of life in CIDPPietro Emiliano Doneddu, Elisa Bianchi, Dario Cocito, et al.
European Journal of Neurology|March 23, 2022
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseasesKatina Aleksovska, Teia Kobulashvili, Joao Costa, et al.
Neurology|June 2, 2023
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical TrialAmel Karaa, Enrico Bertini, Valerio Carelli, et al.
Brain : a Journal of Neurology|July 24, 2024
Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progressionAlexandra Monceau, Rasya Gokul Nath, Xavier Suárez-Calvet, et al.
Pageof 23